1-12 of 12
Ross C. Donehower
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors

Jianqing Lin, Jill Gilbert, Michelle A. Rudek, James A. Zwiebel, Steve Gore, Anchalee Jiemjit, Ming Zhao, Sharyn D. Baker, Richard F. Ambinder, James G. Herman, Ross C. Donehower, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6241–6249.
https://doi.org/10.1158/1078-0432.CCR-09-0567
Published: 30 September 2009
View article titled, A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
Open the PDF for A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors.

Wells A Messersmith, Sharyn D Baker, Lance Lassiter, Rana A Sullivan, Kimberly Dinh, Virna I Almuete, John J Wright, Ross C Donehower, Michael A Carducci, Deborah K Armstrong
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (4): 1270–1275.
https://doi.org/10.1158/1078-0432.CCR-05-1942
Published: 17 February 2006
View article titled, Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors.
Open the PDF for Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors. in another window
Journal Articles

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

E. Claire Dees, Sharyn D. Baker, Seamus O'Reilly, Michelle A. Rudek, Susan B. Davidson, Cheryl Aylesworth, Kathy Elza-Brown, Michael A. Carducci, Ross C. Donehower
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 664–671.
https://doi.org/10.1158/1078-0432.664.11.2
Published: 08 February 2005
View article titled, A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors
Open the PDF for A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors in another window
Journal Articles

Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): Early Termination Due To Increased Toxicities

Wells A. Messersmith, Daniel A. Laheru, Neil N. Senzer, Ross C. Donehower, Paula Grouleff, Theresa Rogers, Sean K. Kelley, David A. Ramies, Bert L. Lum, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6522–6527.
https://doi.org/10.1158/1078-0432.CCR-04-0746
Published: 08 October 2004
View article titled, Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): <subtitle>Early Termination Due To Increased Toxicities</subtitle>
Open the PDF for Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): <subtitle>Early Termination Due To Increased Toxicities</subtitle> in another window
Journal Articles

Phase I Study of Docosahexaenoic Acid-Paclitaxel: a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile

Antonio C. Wolff, Ross C. Donehower, M. Katherine Carducci, Michael A. Carducci, Julie R. Brahmer, Yelena Zabelina, Matthews O. Bradley, Forrest H. Anthony, Charles S. Swindell, Philip A. Witman, Nigel L. Webb, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3589–3597.
Published: 23 September 2003
View article titled, Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle>
Open the PDF for Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle> in another window
Journal Articles

Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: In Vitro and Clinical Pharmacokinetic Studies

Alex Sparreboom, Antonio C. Wolff, Jaap Verweij, Yelena Zabelina, Desiree M. van Zomeren, Gregory L. McIntire, Charles S. Swindell, Ross C. Donehower, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 151–159.
Published: 01 January 2003
View article titled, Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: <subtitle> <em>In Vitro</em> and Clinical Pharmacokinetic Studies</subtitle>
Open the PDF for Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: <subtitle> <em>In Vitro</em> and Clinical Pharmacokinetic Studies</subtitle> in another window
Journal Articles

Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Steven D. Gore, Li-Jun Weng, William D. Figg, Suoping Zhai, Ross C. Donehower, George Dover, Michael R. Grever, Constance Griffin, Louise B. Grochow, Anita Hawkins, Kathleen Burks, Yelena Zabelena, Carole B. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 963–970.
Published: 01 April 2002
View article titled, Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia
Open the PDF for Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia in another window
Journal Articles

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Michael A. Carducci, Jill Gilbert, M. Katherine Bowling, Dennis Noe, Mario A. Eisenberger, Victoria Sinibaldi, Yelena Zabelina, Tian-ling Chen, Louise B. Grochow, Ross C. Donehower
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3047–3055.
Published: 01 October 2001
View article titled, A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule
Open the PDF for A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule in another window
Journal Articles

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Jill Gilbert, Sharyn D. Baker, M. Katherine Bowling, Louise Grochow, W. Douglas Figg, Yelena Zabelina, Ross C. Donehower, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2292–2300.
Published: 01 August 2001
View article titled, A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies
Open the PDF for A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies in another window
Journal Articles

Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Steven D. Gore, Li-Jun Weng, Suoping Zhai, William D. Figg, Ross C. Donehower, George J. Dover, Michael Grever, Constance A. Griffin, Louise B. Grochow, Eric K. Rowinsky, Yelena Zabalena, Anita L. Hawkins, Kathleen Burks, Carole B. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2330–2339.
Published: 01 August 2001
View article titled, Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia
Open the PDF for Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia in another window
Journal Articles

A Phase I and Pharmacologic Evaluation of the DNA Intercalator CI-958 in Patients with Advanced Solid Tumors

E. Claire Dees, Lloyd R. Whitfield, William R. Grove, Sue Rummel, Louise B. Grochow, Ross C. Donehower
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3885–3894.
Published: 01 October 2000
View article titled, A Phase I and Pharmacologic Evaluation of the DNA Intercalator CI-958 in Patients with Advanced Solid Tumors
Open the PDF for A Phase I and Pharmacologic Evaluation of the DNA Intercalator CI-958 in Patients with Advanced Solid Tumors in another window
Journal Articles

Absorption, Metabolism, and Excretion of 14C-Temozolomide following Oral Administration to Patients with Advanced Cancer

Sharyn D. Baker, Mark Wirth, Paul Statkevich, Pascale Reidenberg, Kevin Alton, Susan E. Sartorius, Margaret Dugan, David Cutler, Vijay Batra, Louise B. Grochow, Ross C. Donehower, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 309–317.
Published: 01 February 1999
View article titled, Absorption, Metabolism, and Excretion of <sup>14</sup>C-Temozolomide following Oral Administration to Patients with Advanced Cancer
Open the PDF for Absorption, Metabolism, and Excretion of <sup>14</sup>C-Temozolomide following Oral Administration to Patients with Advanced Cancer in another window